Cutler Group LP Collegium Pharmaceutical, Inc Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Jul 22, 2020	SELL	$15.49 - $23.51 $32,529 - $49,371	-2,100 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$13.89 - $25.45 $29,169 - $53,445	2,100 New	2,100 $3,000
Q3 2019 Oct 28, 2019	SELL	$10.16 - $13.28 $8,128 - $10,624	-800 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$10.62 - $16.59 $11,682 - $18,249	-1,100 Reduced 57.89%	800 $1,000
Q3 2018 Nov 07, 2018	BUY	$14.16 - $24.3 $21,240 - $36,450	1,500 Added 375.0%	1,900 $1,000
Q2 2018 Aug 10, 2018	BUY	$21.79 - $28.29 $6,537 - $8,487	300 Added 300.0%	400 $0
Q1 2018 May 11, 2018	SELL	$18.15 - $29.21 $50,819 - $81,788	-2,800 Reduced 96.55%	100 $0
Q4 2017 Jan 17, 2018	BUY	$9.3 - $19.14 $26,970 - $55,506	2,900	2,900 $8,000

254

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.